Lancashire and South Cumbria
Formulary
6 Endocrine system
06-05-02 Antidiuretic hormone antagonists
Tolvaptan
Formulary
Tablets 15mg, 30mg
Prescribe by brand.
Tolvaptan (Jinarc):
Autosomal dominant polycystic kidney disease (TA358)
Tolvaptan (Samsca):
Treatment of hyponatremia in adults, secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) (No Blueteq form required).
Treatment of SIADH in patients requiring cancer chemotherapy is NHS England commissioned
LSCMMG: Tolvaptan
NICE TA358 Tolvaptan for treating autosomal dominant polycystic kidney disease
Links
LSCMMG: Tolvaptan
Medicines for children: Desmopressin for bedwetting
MHRA: Desmopressin nasal spray: removal of nocturnal enuresis indication
MHRA: Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome
NICE CG111: Bedwetting in under 19s
NICE CG111: Bedwetting in under 19s
NICE CG141: Acute upper gastrointestinal bleeding in over 16s: management
NICE TA358 Tolvaptan for treating autosomal dominant polycystic kidney disease
Key
Full Site